Spirometry
"Spirometry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurement of volume of air inhaled or exhaled by the lung.
| Descriptor ID |
D013147
|
| MeSH Number(s) |
E01.370.386.700.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Spirometry".
Below are MeSH descriptors whose meaning is more specific than "Spirometry".
This graph shows the total number of publications written about "Spirometry" by people in this website by year, and whether "Spirometry" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1997 | 0 | 1 | 1 | | 1998 | 1 | 2 | 3 | | 2000 | 0 | 2 | 2 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 3 | 3 | | 2003 | 0 | 3 | 3 | | 2005 | 1 | 4 | 5 | | 2006 | 0 | 5 | 5 | | 2007 | 0 | 2 | 2 | | 2008 | 0 | 5 | 5 | | 2009 | 0 | 3 | 3 | | 2010 | 1 | 5 | 6 | | 2011 | 0 | 9 | 9 | | 2012 | 0 | 6 | 6 | | 2013 | 0 | 5 | 5 | | 2014 | 0 | 6 | 6 | | 2015 | 1 | 9 | 10 | | 2016 | 1 | 6 | 7 | | 2017 | 1 | 9 | 10 | | 2018 | 0 | 4 | 4 | | 2019 | 1 | 6 | 7 | | 2020 | 2 | 3 | 5 | | 2021 | 0 | 10 | 10 | | 2022 | 0 | 5 | 5 | | 2023 | 1 | 10 | 11 | | 2024 | 3 | 4 | 7 | | 2025 | 2 | 7 | 9 | | 2026 | 1 | 6 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Spirometry" by people in Profiles.
-
Soderlund SA, Masokano BI, Willmering MM, Bdaiwi AS, Hussain R, Kramer EL, Walkup LL, Cleveland ZI. Hyperpolarized Xenon 129 MRI to Evaluate Regional Gas-Exchange Abnormalities in Cystic Fibrosis Lung Disease. Radiol Cardiothorac Imaging. 2026 10; 8(5):e250295.
-
Pistenmaa CL, Doherty L, Hermann EA, Brown AL, Dabelea D, Holguin F, Watson K, Knowler WC, Temprosa M, Barr RG. Lung function after randomization to metformin, lifestyle intervention or placebo in the Diabetes Prevention Program Outcomes Study (DPPOS). Respir Med. 2026 Oct; 262:109077.
-
Hoth KF, Linkenmeyer C, Kinney GL, Newell JD, Regan EA, Make B, Pratte KA, Comellas AP, Hoffman EA, Fortis S, Fiedorowicz JG, DeMeo DL, Yohannes AM, Iyer AS, Foreman MG, Bhatt SP, Kunisaki KM, Lutz SM, Silverman EK, Crapo JD, Austin E. Airway wall thickness and PRISm are associated with cognitive impairment in individuals with cigarette smoking exposure. Respir Res. 2026 Jul 08; 27(1).
-
Boriek AM, Gordon J, Gwon Y, Adami A, Porszasz J, Rossiter HB, Rambod M, Chandra D, Diaz AA, Kinney GL, Make BJ, McDonald MN, Regan EA, Rennard S, van Beek EJR, Casaburi R. Correlates of 5-year decline in 6-min walk distance in the COPDGene cohort. Thorax. 2026 Jun 15; 81(7):664-671.
-
Matheson AM, Prather E, Willmering MM, Mata J, Santyr G, Ratjen FA, Kramer EL, Cleveland ZI, Woods JC. Lung mucus burden and treatment response assessed by MRI in the post-modulator era. J Cyst Fibros. 2026 07; 25(4):711-717.
-
Yadav R, Lippitt WL, Chae KJ, Rieck J, Carlson NE, Liao SY, Mroz MM, Barkes B, Humphries SM, Oh A, Hwang HJ, Parker K, Fuentealba AI, McLaren T, Marrocchio C, Fingerlin TE, Culver DA, Lynch DA, Maier LA. Demographic and Physiological Differences Between Fibrotic and Nonfibrotic CT Subtypes of Sarcoidosis. Chest. 2026 Jul; 170(1):137-148.
-
Fortis S, Comellas AP, Bowler RP, Bhatt SP, Hersh CP, Demeo DL, Kinney G, Silverman EK, Cho MH, Moll M. Relationships between bronchodilator responsiveness, a COPD polygenic risk score, and COPD progression. Respir Med. 2026 02; 252:108636.
-
Matheson AM, Bdaiwi AS, Willmering MM, DiFrancesco MW, Cleveland ZI, Santyr GE, Ratjen F, Kramer EL, Szczesniak RD, Woods JC. Structural and Functional Pulmonary MRI to Predict Pulmonary Exacerbations in Cystic Fibrosis. Chest. 2026 Apr; 169(4):919-931.
-
Diaz AA, Balte PP, Han M, Kalhan R, Bhatt SP, Couper DJ, Jacobs DR, Daviglus ML, Loehr LR, London SJ, O'Connor GT, Schwartz JE, Gharib SA, Chaves PHM, Sanchez TR, Yende S, Bao R, Smith BM, White WB, Martinez FJ, Oelsner EC. Prevalence and Prognostic Significance of COPD in Adults Younger than 50 Years of Age. NEJM Evid. 2025 Aug; 4(8):EVIDoa2400424.
-
Knox-Brown B, Potts J, Franssen FME, Nielsen R, Denguezli M, Rotevatn AØ, Juvekar SK, Cherkaski HH, Studnicka M, Sylvester KP, Mortimer K, Bateman ED, Janson C, Malinovschi A, Seemungal T, Koul P, Mannino D, Mahesh PA, Jogi R, Mejza F, Al Ghobain M, Paraguas SNM, Welte T, Wouters E, Gislason T, Harrabi I, Dias H, Obaseki DO, Kocabas A, Barbara C, Cardoso J, Agarwal D, Nafees AA, Rodrigues F, Garcia-Larsen V, Erhabor GE, Loh LC, Amaral AFS. Concordance between FVC and FEV6 for identifying chronic airflow obstruction and spirometric restriction in the Burden of Obstructive Lung Disease (BOLD) study. BMJ Open Respir Res. 2025 Jul 13; 12(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|